| Literature identifier | Study type | Test dosage | Effective dosage | Endocrine-mediated endpoints | Systems-level perturbations |
|---|---|---|---|---|---|
| PMID:31400790 | IVR | 0.164 mg/kg | 0.164 mg/kg | Decreased cholesterol levels | Metabolic endocrine-mediated perturbations |
| IVR | 0.164 mg/kg | 0.164 mg/kg | Decreased triglycerides level | Metabolic endocrine-mediated perturbations | |
| IVR | 0.164 mg/kg | 0.164 mg/kg | Decreased estradiol levels | Reproductive endocrine-mediated perturbations | |
| IVR | 0.164 mg/kg | 0.164 mg/kg | Increased levels of adrenocortical hormones (ACTH) | Metabolic endocrine-mediated perturbations | |
| IVR | 0.164 mg/kg | 0.164 mg/kg | Decrease in corticosterone levels | Neurological endocrine-mediated perturbations | |
| IVR | 1.64 mg/kg | 1.64 mg/kg | Affects steroid metabolism | Metabolic endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
| IVR | 1.64 mg/kg | 1.64 mg/kg | Decreased estradiol levels | Reproductive endocrine-mediated perturbations | |
| IVR | 1.64 mg/kg | 1.64 mg/kg | Decreased cholesterol levels | Metabolic endocrine-mediated perturbations | |
| IVR | 1.64 mg/kg | 1.64 mg/kg | Decrease in corticosterone levels | Neurological endocrine-mediated perturbations | |
| IVR | 1.64 mg/kg | 1.64 mg/kg | Increased levels of adrenocortical hormones (ACTH) | Metabolic endocrine-mediated perturbations | |
| IVR | 1.64 mg/kg | 1.64 mg/kg | Decreased triglycerides level | Metabolic endocrine-mediated perturbations | |
| IVR | 1.64 mg/kg | 1.64 mg/kg | Reduced acetylcholinesterase activity | Neurological endocrine-mediated perturbations |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.